Related Experiment Video
Updated: May 20, 2026
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Applying next-generation sequencing to pancreatic cancer treatment
1The Genome Institute, Washington University School of Medicine, Campus Box 8501, 4444 Forest Park Avenue, St Louis, MO 63108, USA. emardis@wustl.edu
Abstract:
Pancreatic cancer is a highly lethal malignancy that presents multiple technical challenges for genomic studies. Next-generation sequencing and its applications have proven successful in the study of other tumour types, unravelling the interplay between DNA and RNA changes that are unique to the tumour. This Review outlines the genomic studies performed to date that have explored the somatic alterations of pancreatic cancer genomes, setting the stage for the introduction of our current technological capabilities. In spite of several challenging aspects posed by pancreatic tumours in particular and clinical sequencing-based diagnostics in general, next-generation sequencing and analysis can now be used in experiments relating to the treatment of patients with this disease. As a means to improve patient outcomes, the application of comprehensive next-generation sequencing and analysis to the genomes of patients with pancreatic cancer to identify therapeutic options is proposed.
Insights
Next-generation sequencing (NGS) offers powerful tools for understanding pancreatic cancer genomics. Applying comprehensive NGS analysis can identify new therapeutic options to improve patient outcomes for this lethal disease.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Pancreatic cancer is a lethal malignancy with significant genomic complexity.
- Genomic studies face technical challenges, hindering a full understanding of tumor-specific DNA and RNA alterations.
Purpose of the Study:
- To review existing genomic studies on pancreatic cancer.
- To highlight the utility of next-generation sequencing (NGS) in pancreatic cancer research and diagnostics.
- To propose the application of comprehensive NGS for identifying therapeutic strategies.
Main Methods:
- Review of published genomic studies on pancreatic cancer.
- Discussion of next-generation sequencing technologies and their application.
- Analysis of challenges in clinical sequencing for pancreatic tumors.
Main Results:
- NGS has been successful in characterizing genomic alterations in other cancers.
- Despite challenges, NGS is now feasible for pancreatic cancer research and clinical applications.
- Somatic alterations in pancreatic cancer genomes have been explored through various genomic studies.
Conclusions:
- Next-generation sequencing provides critical insights into pancreatic cancer genomics.
- Comprehensive NGS analysis holds promise for personalized treatment strategies.
- The application of NGS can improve patient outcomes in pancreatic cancer.
